471 patents
Page 24 of 24
Utility
Cyclin Dependent Kinase Inhibitors
30 Oct 19
Ping Chen, Sujin Cho-Schultz, Judith Gail Deal, Gary Michael Gallego, Mehran Jalaie, Robert Steven Kania, Sajiv Krishnan Nair, Sacha Ninkovic, Suvi Tuula Marjukka Orr, Cynthia Louise Palmer
Filed: 22 Apr 19
Utility
Dosing Regimen of Avelumab for the Treatment of Cancer
30 Oct 19
The present invention relates to dosing regimen of avelumab for the treatment of cancer.
Glen Ian Andrews, Carlo Leonel BELLO, Satjit Singh BRAR, Shaonan WANG, Pascal GIRARD
Filed: 4 Oct 17
Utility
Glycoconjugation Process
30 Oct 19
The present disclosure relates generally to methods of preparing glycoconjugates containing a saccharide conjugated to a carrier protein by use of stable nitroxyl radical related agent/oxidant as an oxidizing agent, to immunogenic compositions comprising such glycoconjugates, and to methods for the use of such glycoconjugates and immunogenic compositions.
Mingming Han, Rajesh Kumar Kainthan, Jin-Hwan Kim, Avvari Krishna Prasad
Filed: 8 Jul 19
Utility
Cancer Treatment
30 Oct 19
Diagnostic methods for predicting whether a human tumor is sensitive to treatment with axitinib, and methods of treating a human tumor are disclosed.
Jean-François André MARTINI, Jamal Christo TARAZI, James Andrew WILLIAMS
Filed: 28 Feb 19
Utility
Tumor Necrosis Factor-like Ligand 1A Specific Antibodies and Compositions and Uses Thereof
30 Oct 19
The present invention provides antibodies, or antigen-binding fragment thereof, which specifically bind to TL1A.
Robert Arch, Jun Zhang, Michelle Mader, Tetsuya Ishino, Joel Bard, William Finlay, Orla Cunningham, Ciara Reilly, Peter Brams, Brigitte Devaux, Haichun Huang, Karla Henning
Filed: 23 May 19
Utility
SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL Compounds As Targeting Agents of Asgpr
23 Oct 19
Spiros Liras, Vincent Mascitti, Benjamin Thuma
Filed: 23 Jun 19
Utility
Imidazopyridazine Compounds
23 Oct 19
Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Simone Sciabola, Erik Alphie LaChapelle, Joseph Michael Young, Patrick Robert Verhoest
Filed: 26 Jun 19
Utility
Novel Pyrimidine Carboxamides As Inhibitors of VANIN-1 Enzyme
16 Oct 19
Agustin Casimiro-Garcia, Joseph Walter Strohbach, David Hepworth, Frank Eldridge Lovering, Chulho Choi, Christophe Philippe Allais, Stephen Wayne Wright
Filed: 6 Jul 17
Utility
Stable Liquid Antibody Formulation
16 Oct 19
The present invention relates generally to the field of pharmaceutical formulations of antibodies.
Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Atlanta Lea Lary
Filed: 13 Dec 18
Utility
6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE Compounds
2 Oct 19
Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Simone Sciabola, Erik Alphie LaChapelle, Travis T. Wager, Matthew Merrill Hayward
Filed: 30 May 19
Utility
Antibodies to MAdCAM
2 Oct 19
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to MAdCAM, preferably human MAdCAM and that function to inhibit MAdCAM.
Nicholas Pullen, Elizabeth Molloy, Sirid-Aimee Kellermann, Larry L. Green, Mary Haak-Frendscho
Filed: 20 Feb 19